Assignment of Assignor's Interest

Recorded: 2022-08-11 Pages: 8

Assignor

SETHI, DHRUV KAM

Executed: 2021-03-30

Assignee

OBSIDIAN THERAPEUTICS, INC.

1030 MASSACHUSETTS AVENUE, SUITE 400, CAMBRIDGE, MASSACHUSETTS, 02138

Covered Property (1)

CA2-IL15 Fusion Proteins for Tunable Regulation

Application: 17/753,594 →

Publication: US 2022/0332780

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.